These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6782731)

  • 41. Further studies on the inactivation of slow-reacting substance of anaphylaxis by lipoxidase.
    Sirois P
    Adv Prostaglandin Thromboxane Res; 1980; 6():125-8. PubMed ID: 6770589
    [No Abstract]   [Full Text] [Related]  

  • 42. Inactivation of slow reacting substance of anaphylaxins (SRS-A) by arylsulfatases.
    Orange RP; Murphy RC; Austen KF
    J Immunol; 1974 Jul; 113(1):316-22. PubMed ID: 4832311
    [No Abstract]   [Full Text] [Related]  

  • 43. Inactivation of slow reacting substance of anaphylaxis (SRS-A) by lipoxidase.
    Sirois P
    Prostaglandins; 1979 Mar; 17(3):395-404. PubMed ID: 112651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Anti-slow reacting substance of anaphylaxis effect of verapamil].
    Zhang HQ; Bian RL
    Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):110-2. PubMed ID: 2934942
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hypothesis on the inactivation mechanism of slow reacting substance of anaphylaxis (SRS-A)].
    Sirois P; Borgeat P
    Union Med Can; 1980 Nov; 109(11):1642-6. PubMed ID: 6782731
    [No Abstract]   [Full Text] [Related]  

  • 46. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anaphylaxis during anaesthesia: diagnostic approach.
    Ebo DG; Fisher MM; Hagendorens MM; Bridts CH; Stevens WJ
    Allergy; 2007 May; 62(5):471-87. PubMed ID: 17441788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Leucotriens: conclusion of 40 years' research on mediators of anaphylaxis].
    Borgeat P; Sirois P
    Union Med Can; 1980 Apr; 109(4):557-67. PubMed ID: 7006180
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.